AustralieFrV1, PascalFrancis, Corpus, bibRecord, 002564

Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action

Identifieur interne : 002564 ( PascalFrancis/Corpus ); précédent : 002563; suivant : 002565

Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action

Auteurs : Ben J. Marais ; Mario C. Raviglione ; Peter R. Donald ; Anthony D. Harries ; Afranio L. Kritski ; Stephen M. Graham ; Wafaa M. El-Sadr ; Mark Harrington ; Gavin Churchyard ; Peter Mwaba ; Ian Sanne ; Stefan H. E. Kaufmann ; Christopher J. M. Whitty ; Rifat Atun ; Alimuddin Zumla

Source :

Lancet : (British edition) [ 0140-6736 ] ; 2010.

RBID : Pascal:10-0324505

Descripteurs français

Pascal (Inist)
- Tuberculose, Echelle d'évaluation, Recherche scientifique, Priorité, Diagnostic, Conduite à tenir, Surveillance, Contrôle, Médecine.

English descriptors

KwdEn :
- Check, Clinical management, Diagnosis, Evaluation scale, Medicine, Priority, Scientific research, Surveillance, Tuberculosis.

Abstract

The Millennium Development Goal target for tuberculosis control is to halt the spread of tuberculosis by 2015, and begin to reverse the worldwide incidence. After the introduction of standard control practices in 1995, 36 million people were cured and about 6 million deaths were averted. However, substantial scientific advances and innovative solutions are urgently needed together with creative new strategies. Strong international and national political commitment is essential. Urgent action is needed by national governments to fund their own programmes, and for the G8 countries and other donor governments and organisations to support governmental and non-governmental efforts. To foster the global need for urgent action to control the tuberculosis epidemic, The Lancet, in collaboration with the Stop TB Partnership, WHO, Global Fund to Fight AIDS, Tuberculosis and Malaria, and the experts participating in this Series, is launching The Lancet TB Observatory, which will assess and monitor progress in tuberculosis control and research, assess domestic and global financing, regularly disseminate information, and advocate for intensified efforts with stakeholders at all levels.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0140-6736`
A02	`01`			`@0 LANCAO`
A03		`1`		`@0 Lancet : (Br. ed.)`
A05				`@2 375`
A06				`@2 9732`
A08	`01`	`1`	`ENG`	`@1 Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action`
A11	`01`	`1`		`@1 MARAIS (Ben J.)`
A11	`02`	`1`		`@1 RAVIGLIONE (Mario C.)`
A11	`03`	`1`		`@1 DONALD (Peter R.)`
A11	`04`	`1`		`@1 HARRIES (Anthony D.)`
A11	`05`	`1`		`@1 KRITSKI (Afranio L.)`
A11	`06`	`1`		`@1 GRAHAM (Stephen M.)`
A11	`07`	`1`		`@1 EL-SADR (Wafaa M.)`
A11	`08`	`1`		`@1 HARRINGTON (Mark)`
A11	`09`	`1`		`@1 CHURCHYARD (Gavin)`
A11	`10`	`1`		`@1 MWABA (Peter)`
A11	`11`	`1`		`@1 SANNE (Ian)`
A11	`12`	`1`		`@1 KAUFMANN (Stefan H. E.)`
A11	`13`	`1`		`@1 WHITTY (Christopher J. M.)`
A11	`14`	`1`		`@1 ATUN (Rifat)`
A11	`15`	`1`		`@1 ZUMLA (Alimuddin)`
A14	`01`			`@1 Department of Paediatrics and Child Health, Tygerberg Children's Hospital, Stellenbosch University @2 Tygerberg @3 ZAF @Z 1 aut. @Z 3 aut.`
A14	`02`			`@1 StopTB Department, WHO @2 Geneva @3 CHE @Z 2 aut.`
A14	`03`			`@1 International Union against Tuberculosis and Lung Disease @2 Paris @3 FRA @Z 4 aut. @Z 6 aut.`
A14	`04`			`@1 London School of Hygiene andTropical Medicine @2 London @3 GBR @Z 4 aut. @Z 13 aut.`
A14	`05`			`@1 TuberculosisAcademic Program, Medical School of Federal University of Rio de Janeiro @2 Rio de Janeiro @3 BRA @Z 5 aut.`
A14	`06`			`@1 Brazilian Tuberculosis Research Network (Rede-TB) @2 Rio de Janeiro @3 BRA @Z 5 aut.`
A14	`07`			`@1 Centre for International Child Health, University of Melbourne Department of Paediatrics and Murdoch Childrens' Research Institute, Royal Children's Hospital @2 Melbourne, VIC @3 AUS @Z 6 aut.`
A14	`08`			`@1 International Center for AIDS Care andTreatment Programs, Mailman School of Public Health, Columbia University and Harlem Hospital Center @2 New York, NY @3 USA @Z 7 aut.`
A14	`09`			`@1 Treatment Action Group @2 New York, NY @3 USA @Z 8 aut.`
A14	`10`			`@1 Aurum Institute for Health Research @2 Marshalltown @3 ZAF @Z 9 aut.`
A14	`11`			`@1 UNZA-UCLMS Research and Training Project, University Teaching Hospital @2 Lusaka @3 ZMB @Z 10 aut. @Z 15 aut.`
A14	`12`			`@1 Department of Medicine, University of the Witwatersrand @2 Johannesburg @3 ZAF @Z 11 aut.`
A14	`13`			`@1 Max Planck Institute for Infection-Biology @2 Berlin @3 DEU @Z 12 aut.`
A14	`14`			`@1 Department for International Development @2 London @3 GBR @Z 13 aut.`
A14	`15`			`@1 Global Fund to Fight AIDS, Tuberculosis and Malaria @2 Geneva @3 CHE @Z 14 aut.`
A14	`16`			`@1 Imperial College @2 London @3 GBR @Z 14 aut.`
A14	`17`			`@1 Department of Infection, University College London Medical School @2 London @3 GBR @Z 15 aut.`
A20				`@1 2179-2191`
A21				`@1 2010`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 5004 @5 354000170559150150`
A44				`@0 0000 @1 © 2010 INIST-CNRS. All rights reserved.`
A45				`@0 87 ref.`
A47	`01`	`1`		`@0 10-0324505`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Lancet : (British edition)`
A66	`01`			`@0 GBR`
C01	`01`		`ENG`	@0 The Millennium Development Goal target for tuberculosis control is to halt the spread of tuberculosis by 2015, and begin to reverse the worldwide incidence. After the introduction of standard control practices in 1995, 36 million people were cured and about 6 million deaths were averted. However, substantial scientific advances and innovative solutions are urgently needed together with creative new strategies. Strong international and national political commitment is essential. Urgent action is needed by national governments to fund their own programmes, and for the G8 countries and other donor governments and organisations to support governmental and non-governmental efforts. To foster the global need for urgent action to control the tuberculosis epidemic, The Lancet, in collaboration with the Stop TB Partnership, WHO, Global Fund to Fight AIDS, Tuberculosis and Malaria, and the experts participating in this Series, is launching The Lancet TB Observatory, which will assess and monitor progress in tuberculosis control and research, assess domestic and global financing, regularly disseminate information, and advocate for intensified efforts with stakeholders at all levels.
C02	`01`	`X`		`@0 002B01`
C02	`02`	`X`		`@0 002B05B02O`
C03	`01`	`X`	`FRE`	`@0 Tuberculose @5 01`
C03	`01`	`X`	`ENG`	`@0 Tuberculosis @5 01`
C03	`01`	`X`	`SPA`	`@0 Tuberculosis @5 01`
C03	`02`	`X`	`FRE`	`@0 Echelle d'évaluation @5 02`
C03	`02`	`X`	`ENG`	`@0 Evaluation scale @5 02`
C03	`02`	`X`	`SPA`	`@0 Escala evaluación @5 02`
C03	`03`	`X`	`FRE`	`@0 Recherche scientifique @5 03`
C03	`03`	`X`	`ENG`	`@0 Scientific research @5 03`
C03	`03`	`X`	`SPA`	`@0 Investigación científica @5 03`
C03	`04`	`X`	`FRE`	`@0 Priorité @5 05`
C03	`04`	`X`	`ENG`	`@0 Priority @5 05`
C03	`04`	`X`	`SPA`	`@0 Prioridad @5 05`
C03	`05`	`X`	`FRE`	`@0 Diagnostic @5 06`
C03	`05`	`X`	`ENG`	`@0 Diagnosis @5 06`
C03	`05`	`X`	`SPA`	`@0 Diagnóstico @5 06`
C03	`06`	`X`	`FRE`	`@0 Conduite à tenir @5 08`
C03	`06`	`X`	`ENG`	`@0 Clinical management @5 08`
C03	`06`	`X`	`SPA`	`@0 Actitud médica @5 08`
C03	`07`	`X`	`FRE`	`@0 Surveillance @5 09`
C03	`07`	`X`	`ENG`	`@0 Surveillance @5 09`
C03	`07`	`X`	`SPA`	`@0 Vigilancia @5 09`
C03	`08`	`X`	`FRE`	`@0 Contrôle @5 11`
C03	`08`	`X`	`ENG`	`@0 Check @5 11`
C03	`08`	`X`	`SPA`	`@0 Control @5 11`
C03	`09`	`X`	`FRE`	`@0 Médecine @5 12`
C03	`09`	`X`	`ENG`	`@0 Medicine @5 12`
C03	`09`	`X`	`SPA`	`@0 Medicina @5 12`
C07	`01`	`X`	`FRE`	`@0 Mycobactériose`
C07	`01`	`X`	`ENG`	`@0 Mycobacterial infection`
C07	`01`	`X`	`SPA`	`@0 Micobacteriosis`
C07	`02`	`X`	`FRE`	`@0 Bactériose`
C07	`02`	`X`	`ENG`	`@0 Bacteriosis`
C07	`02`	`X`	`SPA`	`@0 Bacteriosis`
C07	`03`	`X`	`FRE`	`@0 Infection`
C07	`03`	`X`	`ENG`	`@0 Infection`
C07	`03`	`X`	`SPA`	`@0 Infección`
N21				`@1 207`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Format Inist (serveur)

NO :	PASCAL 10-0324505 INIST
ET :	Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action
AU :	MARAIS (Ben J.); RAVIGLIONE (Mario C.); DONALD (Peter R.); HARRIES (Anthony D.); KRITSKI (Afranio L.); GRAHAM (Stephen M.); EL-SADR (Wafaa M.); HARRINGTON (Mark); CHURCHYARD (Gavin); MWABA (Peter); SANNE (Ian); KAUFMANN (Stefan H. E.); WHITTY (Christopher J. M.); ATUN (Rifat); ZUMLA (Alimuddin)
AF :	Department of Paediatrics and Child Health, Tygerberg Children's Hospital, Stellenbosch University/Tygerberg/Afrique du Sud (1 aut., 3 aut.); StopTB Department, WHO/Geneva/Suisse (2 aut.); International Union against Tuberculosis and Lung Disease/Paris/France (4 aut., 6 aut.); London School of Hygiene andTropical Medicine/London/Royaume-Uni (4 aut., 13 aut.); TuberculosisAcademic Program, Medical School of Federal University of Rio de Janeiro/Rio de Janeiro/Brésil (5 aut.); Brazilian Tuberculosis Research Network (Rede-TB)/Rio de Janeiro/Brésil (5 aut.); Centre for International Child Health, University of Melbourne Department of Paediatrics and Murdoch Childrens' Research Institute, Royal Children's Hospital/Melbourne, VIC/Australie (6 aut.); International Center for AIDS Care andTreatment Programs, Mailman School of Public Health, Columbia University and Harlem Hospital Center/New York, NY/Etats-Unis (7 aut.); Treatment Action Group/New York, NY/Etats-Unis (8 aut.); Aurum Institute for Health Research/Marshalltown/Afrique du Sud (9 aut.); UNZA-UCLMS Research and Training Project, University Teaching Hospital/Lusaka/Zambie (10 aut., 15 aut.); Department of Medicine, University of the Witwatersrand/Johannesburg/Afrique du Sud (11 aut.); Max Planck Institute for Infection-Biology/Berlin/Allemagne (12 aut.); Department for International Development/London/Royaume-Uni (13 aut.); Global Fund to Fight AIDS, Tuberculosis and Malaria/Geneva/Suisse (14 aut.); Imperial College/London/Royaume-Uni (14 aut.); Department of Infection, University College London Medical School/London/Royaume-Uni (15 aut.)
DT :	Publication en série; Niveau analytique
SO :	Lancet : (British edition); ISSN 0140-6736; Coden LANCAO; Royaume-Uni; Da. 2010; Vol. 375; No. 9732; Pp. 2179-2191; Bibl. 87 ref.
LA :	Anglais
EA :	The Millennium Development Goal target for tuberculosis control is to halt the spread of tuberculosis by 2015, and begin to reverse the worldwide incidence. After the introduction of standard control practices in 1995, 36 million people were cured and about 6 million deaths were averted. However, substantial scientific advances and innovative solutions are urgently needed together with creative new strategies. Strong international and national political commitment is essential. Urgent action is needed by national governments to fund their own programmes, and for the G8 countries and other donor governments and organisations to support governmental and non-governmental efforts. To foster the global need for urgent action to control the tuberculosis epidemic, The Lancet, in collaboration with the Stop TB Partnership, WHO, Global Fund to Fight AIDS, Tuberculosis and Malaria, and the experts participating in this Series, is launching The Lancet TB Observatory, which will assess and monitor progress in tuberculosis control and research, assess domestic and global financing, regularly disseminate information, and advocate for intensified efforts with stakeholders at all levels.
CC :	002B01; 002B05B02O
FD :	Tuberculose; Echelle d'évaluation; Recherche scientifique; Priorité; Diagnostic; Conduite à tenir; Surveillance; Contrôle; Médecine
FG :	Mycobactériose; Bactériose; Infection
ED :	Tuberculosis; Evaluation scale; Scientific research; Priority; Diagnosis; Clinical management; Surveillance; Check; Medicine
EG :	Mycobacterial infection; Bacteriosis; Infection
SD :	Tuberculosis; Escala evaluación; Investigación científica; Prioridad; Diagnóstico; Actitud médica; Vigilancia; Control; Medicina
LO :	INIST-5004.354000170559150150
ID :	10-0324505

Links to Exploration step

Pascal:10-0324505

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action</title>
<author><name sortKey="Marais, Ben J" sort="Marais, Ben J" uniqKey="Marais B" first="Ben J." last="Marais">Ben J. Marais</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Paediatrics and Child Health, Tygerberg Children's Hospital, Stellenbosch University</s1>
<s2>Tygerberg</s2>
<s3>ZAF</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Raviglione, Mario C" sort="Raviglione, Mario C" uniqKey="Raviglione M" first="Mario C." last="Raviglione">Mario C. Raviglione</name>
<affiliation><inist:fA14 i1="02"><s1>StopTB Department, WHO</s1>
<s2>Geneva</s2>
<s3>CHE</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Donald, Peter R" sort="Donald, Peter R" uniqKey="Donald P" first="Peter R." last="Donald">Peter R. Donald</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Paediatrics and Child Health, Tygerberg Children's Hospital, Stellenbosch University</s1>
<s2>Tygerberg</s2>
<s3>ZAF</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Harries, Anthony D" sort="Harries, Anthony D" uniqKey="Harries A" first="Anthony D." last="Harries">Anthony D. Harries</name>
<affiliation><inist:fA14 i1="03"><s1>International Union against Tuberculosis and Lung Disease</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="04"><s1>London School of Hygiene andTropical Medicine</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>4 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kritski, Afranio L" sort="Kritski, Afranio L" uniqKey="Kritski A" first="Afranio L." last="Kritski">Afranio L. Kritski</name>
<affiliation><inist:fA14 i1="05"><s1>TuberculosisAcademic Program, Medical School of Federal University of Rio de Janeiro</s1>
<s2>Rio de Janeiro</s2>
<s3>BRA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="06"><s1>Brazilian Tuberculosis Research Network (Rede-TB)</s1>
<s2>Rio de Janeiro</s2>
<s3>BRA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Graham, Stephen M" sort="Graham, Stephen M" uniqKey="Graham S" first="Stephen M." last="Graham">Stephen M. Graham</name>
<affiliation><inist:fA14 i1="03"><s1>International Union against Tuberculosis and Lung Disease</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="07"><s1>Centre for International Child Health, University of Melbourne Department of Paediatrics and Murdoch Childrens' Research Institute, Royal Children's Hospital</s1>
<s2>Melbourne, VIC</s2>
<s3>AUS</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="El Sadr, Wafaa M" sort="El Sadr, Wafaa M" uniqKey="El Sadr W" first="Wafaa M." last="El-Sadr">Wafaa M. El-Sadr</name>
<affiliation><inist:fA14 i1="08"><s1>International Center for AIDS Care andTreatment Programs, Mailman School of Public Health, Columbia University and Harlem Hospital Center</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Harrington, Mark" sort="Harrington, Mark" uniqKey="Harrington M" first="Mark" last="Harrington">Mark Harrington</name>
<affiliation><inist:fA14 i1="09"><s1>Treatment Action Group</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Churchyard, Gavin" sort="Churchyard, Gavin" uniqKey="Churchyard G" first="Gavin" last="Churchyard">Gavin Churchyard</name>
<affiliation><inist:fA14 i1="10"><s1>Aurum Institute for Health Research</s1>
<s2>Marshalltown</s2>
<s3>ZAF</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mwaba, Peter" sort="Mwaba, Peter" uniqKey="Mwaba P" first="Peter" last="Mwaba">Peter Mwaba</name>
<affiliation><inist:fA14 i1="11"><s1>UNZA-UCLMS Research and Training Project, University Teaching Hospital</s1>
<s2>Lusaka</s2>
<s3>ZMB</s3>
<sZ>10 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Sanne, Ian" sort="Sanne, Ian" uniqKey="Sanne I" first="Ian" last="Sanne">Ian Sanne</name>
<affiliation><inist:fA14 i1="12"><s1>Department of Medicine, University of the Witwatersrand</s1>
<s2>Johannesburg</s2>
<s3>ZAF</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kaufmann, Stefan H E" sort="Kaufmann, Stefan H E" uniqKey="Kaufmann S" first="Stefan H. E." last="Kaufmann">Stefan H. E. Kaufmann</name>
<affiliation><inist:fA14 i1="13"><s1>Max Planck Institute for Infection-Biology</s1>
<s2>Berlin</s2>
<s3>DEU</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Whitty, Christopher J M" sort="Whitty, Christopher J M" uniqKey="Whitty C" first="Christopher J. M." last="Whitty">Christopher J. M. Whitty</name>
<affiliation><inist:fA14 i1="04"><s1>London School of Hygiene andTropical Medicine</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>4 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="14"><s1>Department for International Development</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Atun, Rifat" sort="Atun, Rifat" uniqKey="Atun R" first="Rifat" last="Atun">Rifat Atun</name>
<affiliation><inist:fA14 i1="15"><s1>Global Fund to Fight AIDS, Tuberculosis and Malaria</s1>
<s2>Geneva</s2>
<s3>CHE</s3>
<sZ>14 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="16"><s1>Imperial College</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>14 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Zumla, Alimuddin" sort="Zumla, Alimuddin" uniqKey="Zumla A" first="Alimuddin" last="Zumla">Alimuddin Zumla</name>
<affiliation><inist:fA14 i1="11"><s1>UNZA-UCLMS Research and Training Project, University Teaching Hospital</s1>
<s2>Lusaka</s2>
<s3>ZMB</s3>
<sZ>10 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="17"><s1>Department of Infection, University College London Medical School</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">10-0324505</idno>
<date when="2010">2010</date>
<idno type="stanalyst">PASCAL 10-0324505 INIST</idno>
<idno type="RBID">Pascal:10-0324505</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002564</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action</title>
<author><name sortKey="Marais, Ben J" sort="Marais, Ben J" uniqKey="Marais B" first="Ben J." last="Marais">Ben J. Marais</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Paediatrics and Child Health, Tygerberg Children's Hospital, Stellenbosch University</s1>
<s2>Tygerberg</s2>
<s3>ZAF</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Raviglione, Mario C" sort="Raviglione, Mario C" uniqKey="Raviglione M" first="Mario C." last="Raviglione">Mario C. Raviglione</name>
<affiliation><inist:fA14 i1="02"><s1>StopTB Department, WHO</s1>
<s2>Geneva</s2>
<s3>CHE</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Donald, Peter R" sort="Donald, Peter R" uniqKey="Donald P" first="Peter R." last="Donald">Peter R. Donald</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Paediatrics and Child Health, Tygerberg Children's Hospital, Stellenbosch University</s1>
<s2>Tygerberg</s2>
<s3>ZAF</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Harries, Anthony D" sort="Harries, Anthony D" uniqKey="Harries A" first="Anthony D." last="Harries">Anthony D. Harries</name>
<affiliation><inist:fA14 i1="03"><s1>International Union against Tuberculosis and Lung Disease</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="04"><s1>London School of Hygiene andTropical Medicine</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>4 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kritski, Afranio L" sort="Kritski, Afranio L" uniqKey="Kritski A" first="Afranio L." last="Kritski">Afranio L. Kritski</name>
<affiliation><inist:fA14 i1="05"><s1>TuberculosisAcademic Program, Medical School of Federal University of Rio de Janeiro</s1>
<s2>Rio de Janeiro</s2>
<s3>BRA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="06"><s1>Brazilian Tuberculosis Research Network (Rede-TB)</s1>
<s2>Rio de Janeiro</s2>
<s3>BRA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Graham, Stephen M" sort="Graham, Stephen M" uniqKey="Graham S" first="Stephen M." last="Graham">Stephen M. Graham</name>
<affiliation><inist:fA14 i1="03"><s1>International Union against Tuberculosis and Lung Disease</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="07"><s1>Centre for International Child Health, University of Melbourne Department of Paediatrics and Murdoch Childrens' Research Institute, Royal Children's Hospital</s1>
<s2>Melbourne, VIC</s2>
<s3>AUS</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="El Sadr, Wafaa M" sort="El Sadr, Wafaa M" uniqKey="El Sadr W" first="Wafaa M." last="El-Sadr">Wafaa M. El-Sadr</name>
<affiliation><inist:fA14 i1="08"><s1>International Center for AIDS Care andTreatment Programs, Mailman School of Public Health, Columbia University and Harlem Hospital Center</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Harrington, Mark" sort="Harrington, Mark" uniqKey="Harrington M" first="Mark" last="Harrington">Mark Harrington</name>
<affiliation><inist:fA14 i1="09"><s1>Treatment Action Group</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Churchyard, Gavin" sort="Churchyard, Gavin" uniqKey="Churchyard G" first="Gavin" last="Churchyard">Gavin Churchyard</name>
<affiliation><inist:fA14 i1="10"><s1>Aurum Institute for Health Research</s1>
<s2>Marshalltown</s2>
<s3>ZAF</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mwaba, Peter" sort="Mwaba, Peter" uniqKey="Mwaba P" first="Peter" last="Mwaba">Peter Mwaba</name>
<affiliation><inist:fA14 i1="11"><s1>UNZA-UCLMS Research and Training Project, University Teaching Hospital</s1>
<s2>Lusaka</s2>
<s3>ZMB</s3>
<sZ>10 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Sanne, Ian" sort="Sanne, Ian" uniqKey="Sanne I" first="Ian" last="Sanne">Ian Sanne</name>
<affiliation><inist:fA14 i1="12"><s1>Department of Medicine, University of the Witwatersrand</s1>
<s2>Johannesburg</s2>
<s3>ZAF</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kaufmann, Stefan H E" sort="Kaufmann, Stefan H E" uniqKey="Kaufmann S" first="Stefan H. E." last="Kaufmann">Stefan H. E. Kaufmann</name>
<affiliation><inist:fA14 i1="13"><s1>Max Planck Institute for Infection-Biology</s1>
<s2>Berlin</s2>
<s3>DEU</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Whitty, Christopher J M" sort="Whitty, Christopher J M" uniqKey="Whitty C" first="Christopher J. M." last="Whitty">Christopher J. M. Whitty</name>
<affiliation><inist:fA14 i1="04"><s1>London School of Hygiene andTropical Medicine</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>4 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="14"><s1>Department for International Development</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Atun, Rifat" sort="Atun, Rifat" uniqKey="Atun R" first="Rifat" last="Atun">Rifat Atun</name>
<affiliation><inist:fA14 i1="15"><s1>Global Fund to Fight AIDS, Tuberculosis and Malaria</s1>
<s2>Geneva</s2>
<s3>CHE</s3>
<sZ>14 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="16"><s1>Imperial College</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>14 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Zumla, Alimuddin" sort="Zumla, Alimuddin" uniqKey="Zumla A" first="Alimuddin" last="Zumla">Alimuddin Zumla</name>
<affiliation><inist:fA14 i1="11"><s1>UNZA-UCLMS Research and Training Project, University Teaching Hospital</s1>
<s2>Lusaka</s2>
<s3>ZMB</s3>
<sZ>10 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="17"><s1>Department of Infection, University College London Medical School</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Lancet : (British edition)</title>
<title level="j" type="abbreviated">Lancet : (Br. ed.)</title>
<idno type="ISSN">0140-6736</idno>
<imprint><date when="2010">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Lancet : (British edition)</title>
<title level="j" type="abbreviated">Lancet : (Br. ed.)</title>
<idno type="ISSN">0140-6736</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Check</term>
<term>Clinical management</term>
<term>Diagnosis</term>
<term>Evaluation scale</term>
<term>Medicine</term>
<term>Priority</term>
<term>Scientific research</term>
<term>Surveillance</term>
<term>Tuberculosis</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Tuberculose</term>
<term>Echelle d'évaluation</term>
<term>Recherche scientifique</term>
<term>Priorité</term>
<term>Diagnostic</term>
<term>Conduite à tenir</term>
<term>Surveillance</term>
<term>Contrôle</term>
<term>Médecine</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The Millennium Development Goal target for tuberculosis control is to halt the spread of tuberculosis by 2015, and begin to reverse the worldwide incidence. After the introduction of standard control practices in 1995, 36 million people were cured and about 6 million deaths were averted. However, substantial scientific advances and innovative solutions are urgently needed together with creative new strategies. Strong international and national political commitment is essential. Urgent action is needed by national governments to fund their own programmes, and for the G8 countries and other donor governments and organisations to support governmental and non-governmental efforts. To foster the global need for urgent action to control the tuberculosis epidemic, The Lancet, in collaboration with the Stop TB Partnership, WHO, Global Fund to Fight AIDS, Tuberculosis and Malaria, and the experts participating in this Series, is launching The Lancet TB Observatory, which will assess and monitor progress in tuberculosis control and research, assess domestic and global financing, regularly disseminate information, and advocate for intensified efforts with stakeholders at all levels.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0140-6736</s0>
</fA01>
<fA02 i1="01"><s0>LANCAO</s0>
</fA02>
<fA03 i2="1"><s0>Lancet : (Br. ed.)</s0>
</fA03>
<fA05><s2>375</s2>
</fA05>
<fA06><s2>9732</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>MARAIS (Ben J.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>RAVIGLIONE (Mario C.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>DONALD (Peter R.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>HARRIES (Anthony D.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>KRITSKI (Afranio L.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>GRAHAM (Stephen M.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>EL-SADR (Wafaa M.)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>HARRINGTON (Mark)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>CHURCHYARD (Gavin)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>MWABA (Peter)</s1>
</fA11>
<fA11 i1="11" i2="1"><s1>SANNE (Ian)</s1>
</fA11>
<fA11 i1="12" i2="1"><s1>KAUFMANN (Stefan H. E.)</s1>
</fA11>
<fA11 i1="13" i2="1"><s1>WHITTY (Christopher J. M.)</s1>
</fA11>
<fA11 i1="14" i2="1"><s1>ATUN (Rifat)</s1>
</fA11>
<fA11 i1="15" i2="1"><s1>ZUMLA (Alimuddin)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Paediatrics and Child Health, Tygerberg Children's Hospital, Stellenbosch University</s1>
<s2>Tygerberg</s2>
<s3>ZAF</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>StopTB Department, WHO</s1>
<s2>Geneva</s2>
<s3>CHE</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>International Union against Tuberculosis and Lung Disease</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>London School of Hygiene andTropical Medicine</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>4 aut.</sZ>
<sZ>13 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>TuberculosisAcademic Program, Medical School of Federal University of Rio de Janeiro</s1>
<s2>Rio de Janeiro</s2>
<s3>BRA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Brazilian Tuberculosis Research Network (Rede-TB)</s1>
<s2>Rio de Janeiro</s2>
<s3>BRA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>Centre for International Child Health, University of Melbourne Department of Paediatrics and Murdoch Childrens' Research Institute, Royal Children's Hospital</s1>
<s2>Melbourne, VIC</s2>
<s3>AUS</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="08"><s1>International Center for AIDS Care andTreatment Programs, Mailman School of Public Health, Columbia University and Harlem Hospital Center</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="09"><s1>Treatment Action Group</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="10"><s1>Aurum Institute for Health Research</s1>
<s2>Marshalltown</s2>
<s3>ZAF</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="11"><s1>UNZA-UCLMS Research and Training Project, University Teaching Hospital</s1>
<s2>Lusaka</s2>
<s3>ZMB</s3>
<sZ>10 aut.</sZ>
<sZ>15 aut.</sZ>
</fA14>
<fA14 i1="12"><s1>Department of Medicine, University of the Witwatersrand</s1>
<s2>Johannesburg</s2>
<s3>ZAF</s3>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="13"><s1>Max Planck Institute for Infection-Biology</s1>
<s2>Berlin</s2>
<s3>DEU</s3>
<sZ>12 aut.</sZ>
</fA14>
<fA14 i1="14"><s1>Department for International Development</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>13 aut.</sZ>
</fA14>
<fA14 i1="15"><s1>Global Fund to Fight AIDS, Tuberculosis and Malaria</s1>
<s2>Geneva</s2>
<s3>CHE</s3>
<sZ>14 aut.</sZ>
</fA14>
<fA14 i1="16"><s1>Imperial College</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>14 aut.</sZ>
</fA14>
<fA14 i1="17"><s1>Department of Infection, University College London Medical School</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>15 aut.</sZ>
</fA14>
<fA20><s1>2179-2191</s1>
</fA20>
<fA21><s1>2010</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>5004</s2>
<s5>354000170559150150</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2010 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>87 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>10-0324505</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Lancet : (British edition)</s0>
</fA64>
<fA66 i1="01"><s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>The Millennium Development Goal target for tuberculosis control is to halt the spread of tuberculosis by 2015, and begin to reverse the worldwide incidence. After the introduction of standard control practices in 1995, 36 million people were cured and about 6 million deaths were averted. However, substantial scientific advances and innovative solutions are urgently needed together with creative new strategies. Strong international and national political commitment is essential. Urgent action is needed by national governments to fund their own programmes, and for the G8 countries and other donor governments and organisations to support governmental and non-governmental efforts. To foster the global need for urgent action to control the tuberculosis epidemic, The Lancet, in collaboration with the Stop TB Partnership, WHO, Global Fund to Fight AIDS, Tuberculosis and Malaria, and the experts participating in this Series, is launching The Lancet TB Observatory, which will assess and monitor progress in tuberculosis control and research, assess domestic and global financing, regularly disseminate information, and advocate for intensified efforts with stakeholders at all levels.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B01</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B05B02O</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Tuberculose</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Tuberculosis</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Tuberculosis</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Echelle d'évaluation</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Evaluation scale</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Escala evaluación</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Recherche scientifique</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Scientific research</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Investigación científica</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Priorité</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Priority</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Prioridad</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Diagnostic</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Diagnosis</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Diagnóstico</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Conduite à tenir</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Clinical management</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Actitud médica</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Surveillance</s0>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Surveillance</s0>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Vigilancia</s0>
<s5>09</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Contrôle</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Check</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Control</s0>
<s5>11</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Médecine</s0>
<s5>12</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Medicine</s0>
<s5>12</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Medicina</s0>
<s5>12</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Mycobactériose</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Mycobacterial infection</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Micobacteriosis</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Bactériose</s0>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Bacteriosis</s0>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Bacteriosis</s0>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Infection</s0>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Infection</s0>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Infección</s0>
</fC07>
<fN21><s1>207</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 10-0324505 INIST</NO>
<ET>Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action</ET>
<AU>MARAIS (Ben J.); RAVIGLIONE (Mario C.); DONALD (Peter R.); HARRIES (Anthony D.); KRITSKI (Afranio L.); GRAHAM (Stephen M.); EL-SADR (Wafaa M.); HARRINGTON (Mark); CHURCHYARD (Gavin); MWABA (Peter); SANNE (Ian); KAUFMANN (Stefan H. E.); WHITTY (Christopher J. M.); ATUN (Rifat); ZUMLA (Alimuddin)</AU>
<AF>Department of Paediatrics and Child Health, Tygerberg Children's Hospital, Stellenbosch University/Tygerberg/Afrique du Sud (1 aut., 3 aut.); StopTB Department, WHO/Geneva/Suisse (2 aut.); International Union against Tuberculosis and Lung Disease/Paris/France (4 aut., 6 aut.); London School of Hygiene andTropical Medicine/London/Royaume-Uni (4 aut., 13 aut.); TuberculosisAcademic Program, Medical School of Federal University of Rio de Janeiro/Rio de Janeiro/Brésil (5 aut.); Brazilian Tuberculosis Research Network (Rede-TB)/Rio de Janeiro/Brésil (5 aut.); Centre for International Child Health, University of Melbourne Department of Paediatrics and Murdoch Childrens' Research Institute, Royal Children's Hospital/Melbourne, VIC/Australie (6 aut.); International Center for AIDS Care andTreatment Programs, Mailman School of Public Health, Columbia University and Harlem Hospital Center/New York, NY/Etats-Unis (7 aut.); Treatment Action Group/New York, NY/Etats-Unis (8 aut.); Aurum Institute for Health Research/Marshalltown/Afrique du Sud (9 aut.); UNZA-UCLMS Research and Training Project, University Teaching Hospital/Lusaka/Zambie (10 aut., 15 aut.); Department of Medicine, University of the Witwatersrand/Johannesburg/Afrique du Sud (11 aut.); Max Planck Institute for Infection-Biology/Berlin/Allemagne (12 aut.); Department for International Development/London/Royaume-Uni (13 aut.); Global Fund to Fight AIDS, Tuberculosis and Malaria/Geneva/Suisse (14 aut.); Imperial College/London/Royaume-Uni (14 aut.); Department of Infection, University College London Medical School/London/Royaume-Uni (15 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Lancet : (British edition); ISSN 0140-6736; Coden LANCAO; Royaume-Uni; Da. 2010; Vol. 375; No. 9732; Pp. 2179-2191; Bibl. 87 ref.</SO>
<LA>Anglais</LA>
<EA>The Millennium Development Goal target for tuberculosis control is to halt the spread of tuberculosis by 2015, and begin to reverse the worldwide incidence. After the introduction of standard control practices in 1995, 36 million people were cured and about 6 million deaths were averted. However, substantial scientific advances and innovative solutions are urgently needed together with creative new strategies. Strong international and national political commitment is essential. Urgent action is needed by national governments to fund their own programmes, and for the G8 countries and other donor governments and organisations to support governmental and non-governmental efforts. To foster the global need for urgent action to control the tuberculosis epidemic, The Lancet, in collaboration with the Stop TB Partnership, WHO, Global Fund to Fight AIDS, Tuberculosis and Malaria, and the experts participating in this Series, is launching The Lancet TB Observatory, which will assess and monitor progress in tuberculosis control and research, assess domestic and global financing, regularly disseminate information, and advocate for intensified efforts with stakeholders at all levels.</EA>
<CC>002B01; 002B05B02O</CC>
<FD>Tuberculose; Echelle d'évaluation; Recherche scientifique; Priorité; Diagnostic; Conduite à tenir; Surveillance; Contrôle; Médecine</FD>
<FG>Mycobactériose; Bactériose; Infection</FG>
<ED>Tuberculosis; Evaluation scale; Scientific research; Priority; Diagnosis; Clinical management; Surveillance; Check; Medicine</ED>
<EG>Mycobacterial infection; Bacteriosis; Infection</EG>
<SD>Tuberculosis; Escala evaluación; Investigación científica; Prioridad; Diagnóstico; Actitud médica; Vigilancia; Control; Medicina</SD>
<LO>INIST-5004.354000170559150150</LO>
<ID>10-0324505</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002564 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 002564 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:10-0324505
   |texte=   Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action

Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri